SEC Form 4 · accession 0001747259-18-000001
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giri Devanur
10% Owner
Period of report
Jun 7, 2018
Accepted (ET)
Jul 19, 2018 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jun 7, 2018 | S | 329,357 | $2.0079 | D | 1,861,989 | D | |
| Common stock | Jul 17, 2018 | S | 100,000 | $2.2663 | D | 1,761,989 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $0.27 | Jun 12, 2018 | P | 25,000 | A | — | — | Common stock | 25,000 | 37,121 | D |
Explanation of responses
- F1Undetermined